Structure-based discovery of a new class of Hsp90 inhibitors

被引：73

作者：

Barril, X ^{[1
]}

Brough, P ^{[1
]}

Drysdale, M ^{[1
]}

Hubbard, RE ^{[1
]}

Massey, A ^{[1
]}

Surgenor, A ^{[1
]}

Wright, L ^{[1
]}

机构：

[1] Vernalis R&D Ltd, Cambridge CB1 6GB, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 23期

关键词：

Hsp90; inhibitor; docking; virtual screening; hit identification; phenol-naphthol; bis-phenol; structure-based drug discovery;

D O I：

10.1016/j.bmcl.2005.08.092

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Docking-based virtual screening identified 1-(2-phenol)-2-naphthol compounds as a new class of Hsp90 inhibitors of low to sub-micromolar potency. Here we report the binding affinities and cellular activities of several members of this class. A high resolution crystal structure of the most potent compound reveals its binding mode in the ATP binding site of Hsp90, providing a rationale for the observed activity of the series and suggesting strategies for developing compounds with improved properties. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：5187 / 5191

页数：5

共 30 条

[1] [Anonymous], ACTA CRYSTALLOGR D
[2] Phase I pharmacokinetic and pharmacodynarnic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies
Banerji, U
O'Donnell, A
Scurr, M
Pacey, S
Stapleton, S
Asad, Y
Simmons, L
Maloney, A
Raynaud, F
Campbell, M
Walton, M
Lakhani, S
Kaye, S
Workman, P
Judson, I
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4152 - 4161
[3] Barril X, 2004, MINI-REV MED CHEM, V4, P779
[4] Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds
Baurin, N
Baker, R
Richardson, C
Chen, I
Foloppe, N
Potter, A
Jordan, A
Roughley, S
Parratt, M
Greaney, P
Morley, D
Hubbard, RE
[J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (02): : 643 - 651
[5] Molecular recognition and docking algorithms
Brooijmans, N
Kuntz, ID
[J]. ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2003, 32 : 335 - 373
[6] The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors
Cheung, KMJ
Matthews, TP
James, K
Rowlands, MG
Boxall, KJ
Sharp, SY
Maloney, A
Roe, SM
Prodromou, C
Pearl, LH
Aherne, GW
McDonald, E
Workman, P
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (14) : 3338 - 3343
[7] A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
Chiosis, G
Timaul, MN
Lucas, B
Munster, PN
Zheng, FF
Sepp-Lorenzino, L
Rosen, N
[J]. CHEMISTRY & BIOLOGY, 2001, 8 (03): : 289 - 299
[8] Adenine derived inhibitors of the molecular chaperone HSP90 - SAR explained through multiple X-ray structures
Dymock, B
Barril, X
Beswick, M
Collier, A
Davies, N
Drysdale, M
Fink, A
Fromont, C
Hubbard, RE
Massey, A
Surgenor, A
Wright, L
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (02) : 325 - 328
[9] Inhibitors of HSP90 and other chaperones for the treatment of cancer
Dymock, BW
Drysdale, MJ
McDonald, E
Workman, P
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (06) : 837 - 847
[10] Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design
Dymock, BW
Barril, X
Brough, PA
Cansfield, JE
Massey, A
McDonald, E
Hubbard, RE
Surgenor, A
Roughley, SD
Webb, P
Workman, P
Wright, L
Drysdale, MJ
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (13) : 4212 - 4215

← 1 2 3 →